Arthur Porter, MA, MBA, MD, DMRT, FRCPC, FACR, FACRO, FAAMA
Dr. Arthur T. Porter brings a unique blend of medical practice, finance, and business experience to healthcare leadership. He graduated from UT's Physician Executive MBA program in 1998.
Born in Freetown, Sierra Leone, Dr. Porter's extensive international healthcare background includes medical practice, business and academic leadership positions in Canada, Europe, Africa, and the United States. He has served as a consultant to the World Health Organization and has worked to establish international medical research and treatment programs in Turkey, India, Yemen, Bahamas, Brazil and throughout Europe, including opening a state-of-the-art cancer center in the Bahamas and introducing breakthrough radiation therapy concepts. His major academic endeavor relates to the medical uses of radioactive isotopes and the treatment of prostate cancer.
Dr. Porter currently is Directeur-General and CEO of the McGill University Health Center (MUHC) in Montreal Canada. MUHC is one of the most comprehensive academic health centers in North America with over 1,300 clinicians and 13,000 healthcare professionals. In July 2004, MUHC received $1.1 billion in funding to redevelop the McGill University Health Center into two new campuses. This represents the largest current healthcare project in Canada. As CEO of MUHC, Dr. Porter also plays a leading role in shaping the redesign of the healthcare delivery system for Quebec.
Prior to joining MUHC, Dr. Porter was CEO of the Detroit Medical Center, a $1.6 billion healthcare system. Under his leadership, the system grew to include ten hospitals and institutes, 100 ambulatory sites, 2,000 licensed beds, 3,000 affiliated physicians, and a health plan. Success at Detroit Medical Center was tied to Dr. Porter's commitment to streamlining cost of care, developing the nation's largest outsourced technology contract, and instituting lean time management programs and training to the 14,000-plus employee organization - knowledge he acquired at UT.
Dr. Porter pursued an MBA to acquire business knowledge specific to the healthcare industry. "With the way that healthcare has evolved in the United States, physicians must not only be masters of their trade, but the business environment as well. The doctor who understands the business environment will be more successful than the one who does not."
Dr. Porter currently serves on the Board of Scientific Counselors of the National Cancer Institute and the United States Industrial Coalition. He serves on the board of the Munder Funds; UHMS and Mediguide, both health management companies; and Adherex, a publicly traded biotechnology company.
He has been awarded Fellowships by the American College of Radiation Oncology, the Royal Society of Medicine, the American College of Oncology Administrators, and the American College of Radiology. He is on the editorial board of 13 scientific journals and has more than 300 scholarly works in peer-reviewed journals, books, and conference proceedings. He is involved with several medical task forces, including the presidential commission charged with reviewing healthcare provided by the Department of Defense and the Veterans Administration.
Related Links
Curriculum, Goals and Outcomes
FAQ
Timetable
Admission Information
Technology & Notebook
Fees
& Financial Aid
Accreditation
& Faculty
Profiles
PEMBA in the news
Request Info
Apply Now
Contact This Department
The University of Tennessee
Physician Executive MBA
608 Stokely Management Center
Knoxville, TN 37996
Phone: (865) 974-1772
Fax: (865) 974-0929
Email: click here